Skip to content

An Interpretative Phenomenological Analysis of the use of psilocybin by veterans with symptoms of trauma

FL Smith, JC Neill, V Wainwright

Drug Science Policy and Law January 1, 2022 DOI: 10.1177/20503245221124117 via OpenAlex

Summary

AI-generated from the abstract

Veterans with trauma symptoms often find standard treatments inaccessible or ineffective and may turn to psilocybin. Interviews with seven veterans who had used or considered using psilocybin revealed that all perceived barriers to conventional care, and many considered psilocybin out of desperation. Those who had used psilocybin reported immediate and long-term improvements in their symptoms. The findings suggest that psilocybin may be a viable treatment option for some, but further clinical trials are needed to confirm its therapeutic potential.

Study at a glance

Characteristics Qualitative study Peer reviewed
Sample size 7
Population Veterans with current or historic trauma symptoms who had used or considered using psilocybin
Intervention Psilocybin
Topics Psilocybin
Keywords Interpretative phenomenological analysis Psychiatry Psychotherapist Clinical psychology
Citations 9
Key finding Veterans who used psilocybin reported immediate and long-term improvements in trauma symptoms, suggesting it may be a viable treatment option for some.

Abstract

Veterans are at increased risk of experiencing symptoms of trauma. Although many benefit from available treatments, some find treatment inaccessible or ineffective and explore alternative substances. One such substance is psilocybin. This Interpretative Phenomenological Analysis study aimed to provide an initial insight into the experiences of veterans who have used or have considered using psilocybin and their perspectives regarding the acceptability of it as a treatment for their self-reported symptoms of trauma. Seven veterans with current or historic trauma symptoms were interviewed. All participants had either used or considered using psilocybin to alleviate their symptoms. All participants reported perceiving barriers when accessing treatment with many considering psilocybin out of desperation. All participants who had used psilocybin reported immediate and long-term improvements in their symptomatology. The study suggests that some perceive current treatments as ineffective and/or inaccessible, leading to the consideration of alternatives, such as psilocybin. The immediate and long-term symptom reductions reported suggest it may be a viable treatment option for symptoms of trauma for some. However, further research and clinical trials are required to form conclusions on the therapeutic potential of psilocybin for this group.

Explore topics

Comments

No comments yet.

Log in to comment